By ANGELA TAN
Biosensors International Group, Ltd reported on Friday that its net profit for the fiscal third quarter ended December 31, 2010 was US$13.34 million, compared to US$12.38 million a year ago.
Total product sales in the third quarter were US$37.86 million, up a 27 per cent from a year ago due to the continued growth in the sales of the BioMatrix. family of drug-eluting stents.
It management expects product revenues for the fiscal year ending March 31, 2011to range between US$135 million and US$145 million.
It also believes its goal of increased profitability over FY10 on an overall basis will be achieved in FY11.
---------------------------------------
Createwealth8888:
Will biosensor become the 5th or 6th multi-bagger in the next few years?
Posts
Why This Potential New Singapore Property Rule Could Be A Good Thing For
You In 2025
-
“I’m not sure I want the ‘old bird’ agent,” was the phrase that surprised
me this week. In most situations, people would want a veteran on their
side. Mo...
7 hours ago
No comments:
Post a Comment